Positron Emission Tomography (PET) Imaging of Thrombosis

PHASE1RecruitingINTERVENTIONAL
Enrollment

165

Participants

Timeline

Start Date

April 1, 2016

Primary Completion Date

October 31, 2025

Study Completion Date

January 30, 2026

Conditions
Atrial FibrillationCOVID-19CancerThrombosis
Interventions
DRUG

[64Cu]FBP8

Injection of Copper-64 radiopeptide to detect thrombosis

DEVICE

PET/MR

Whole body imaging using Siemens mMR PET/MR scanner

PROCEDURE

Blood Collection

A total of 9 cc of blood sampled before, during, and after imaging for clinical chemistry

PROCEDURE

Electrocardiogram

A standard 12-lead ECG will be obtained pre-and-post injection with radiotracer

Trial Locations (1)

02114

RECRUITING

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Massachusetts General Hospital

OTHER